Beam Therapeutics
BEAM
BEAM
209 hedge funds and large institutions have $2.18B invested in Beam Therapeutics in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 85 increasing their positions, 57 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $2.6B → $2.18B (-$420M)
34% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 38
56% less call options, than puts
Call options by funds: $8.74M | Put options by funds: $19.7M
Holders
209
Holding in Top 10
3
Calls
$8.74M
Puts
$19.7M
Top Buyers
| 1 | +$20.8M | |
| 2 | +$14.9M | |
| 3 | +$8.9M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$7.42M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$6.51M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$9.48M | |
| 3 | -$9.05M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$6.58M |
| 5 |
BlackRock
New York
|
-$4.98M |